Partner Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$294K Buy
+7,897
New +$281K 2.11% 20
2019
Q3
Sell
-27,670
Closed -$1.14M 91
2019
Q2
$1.14M Sell
27,670
-25,941
-48% -$1.03M 1.21% 31
2019
Q1
$2.16M Buy
53,611
+35,425
+195% +$1.42M 2.5% 10
2018
Q4
$753K Buy
+18,186
New +$755K 0.94% 39
2017
Q4
Sell
-32,738
Closed -$1.11M 90
2017
Q3
$1.11M Buy
+32,738
New +$1.05M 1.05% 35
2015
Q4
Sell
-96,289
Closed -$2.87M 81
2015
Q3
$2.87M Buy
+96,289
New +$3.09M 4.34% 6
2015
Q2
Sell
-41,874
Closed -$1.38M 104
2015
Q1
$1.38M Buy
+41,874
New +$1.33M 2.08% 15
2014
Q2
Sell
-49,911
Closed -$1.52M 74
2014
Q1
$1.52M Buy
49,911
+22,166
+80% +$661K 0.28% 47
2013
Q4
$806K Sell
27,745
-230,629
-89% -$6.71M 0.18% 43
2013
Q3
$7.04M Sell
258,374
-743,403
-74% -$20.2M 1.88% 20
2013
Q2
$26.6M Buy
+1,001,777
New +$27.7M 6.02% 3

Other funds holding PFE

Partner Investment Management's PFE Position: Q4 2019 in Review

Partner Investment Management opened a new position in Pfizer (PFE) in Q4 2019: 7,897 shares worth $294K. The stake represents 2.11% of the portfolio and ranks #20 among its holdings. This is a return to the name: Partner Investment Management previously reported a position in PFE as recently as Q2 2019.

Partner Investment Management first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $26.6M in Q2 2013. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Partner Investment Management held 7,897 shares of Pfizer worth $294K as of Q4 2019.
  • Pfizer was a new Partner Investment Management position in Q4 2019.
  • Pfizer made up 2.11% of Partner Investment Management's portfolio in Q4 2019, its #20 holding.
  • Partner Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
  • Partner Investment Management's Pfizer position peaked at $26.6M in Q2 2013.
  • 2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.